Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Interventional × mirdametinib × Clear all

Phase

Status

Recruiting 7 Completed 6 Terminated 4 Suspended 1 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neurofibromatosis 1 1 Glioma 1 Glioblastoma 1

Interventions

Cisplatin 123 Carboplatin 123 Drug Therapy 102 Bevacizumab 102 Capecitabine 101 Oxaliplatin 100 Paclitaxel 88 Radiotherapy 87 tislelizumab 86 Gemcitabine 85 Cyclophosphamide 85 pembrolizumab 76 Specimen Handling 72 toripalimab 66 Injections 63 Fluorouracil 62 sintilimab 58 Magnetic Resonance Spectroscopy 57 Docetaxel 51 130-nm albumin-bound paclitaxel 50 Surgical Procedures, Operative 48 anlotinib 46 lenvatinib 43 fludarabine 43 Pemetrexed 43 Standard of Care 42 Leucovorin 42 Biopsy 42 Radiosurgery 40 venetoclax 39

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07521657 2026-04-13

NF118

University of Alabama at Birmingham

Phase 2 Not yet recruiting

Glioblastoma, Glioma, Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡